| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Rani Therapeutics Hldgs (NASDAQ:RANI) through any online brokerage.
Other companies in Rani Therapeutics Hldgs’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Rani Therapeutics Hldgs has a consensus price target of $9.18.
The stock price for Rani Therapeutics Hldgs (NASDAQ: RANI) is $0.788 last updated October 9, 2026 at 5:33 PM EDT.
There are no upcoming dividends for Rani Therapeutics Hldgs.
Rani Therapeutics Hldgs does not have any upcoming earnings scheduled.
There is no upcoming split for Rani Therapeutics Hldgs.
Rani Therapeutics Hldgs is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
